Finding new medicines for complex brain and immune system diseases is usually very slow and expensive. To solve this, two major companies, SK Biopharmaceuticals and Insilico Medicine, are teaming up to use Artificial Intelligence to find better drug options much faster. By using this smart technology, they aim to cut down research time, lower costs, and bring new, life-saving treatments to patients around the world much sooner than before.
